Anaconda Biomed Appoints Trent Reutiman New CEO - Yahoo …
Jan 7, 2025 · Reutiman brings more than twenty-five years of executive, financial, market development, and sales operation leadership experience to Anaconda, with an extensive focus in vascular technologies.
Anaconda Biomed Appoints Trent Reutiman New CEO
Jan 7, 2025 · Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has named long-time medtech executive...
Anaconda Biomed Appoints Trent Reutiman as CEO
January 7, 2025—Anaconda Biomed S.L. announced that it named Trent Reutiman its new CEO. The company’s previous CEO Francois Salmon will now serve as Anaconda’s Board Chairman. Anaconda, a developer of thrombectomy systems for treating ischemic stroke is headquartered in Barcelona, Spain.
Anaconda Biomed Welcomes Trent Reutiman as CEO for Growth
Jan 7, 2025 · Anaconda Biomed S.L., a pioneering medical technology company that specializes in the development of advanced thrombectomy systems aimed at treating ischemic stroke, is excited to announce the appointment of Trent Reutiman as its new Chief Executive Officer (CEO).
Anaconda Biomed Appoints Trent Reutiman New CEO
Jan 7, 2025 · BARCELONA, Spain & MARIN, Calif. – (BUSINESS WIRE)– Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has named long-time medtech executive Trent Reutiman as its new CEO.
Anaconda Biomed Appoints Trent Reutiman New CEO
Jan 7, 2025 · BARCELONA, Spain & MARIN, Calif.-- (BUSINESS WIRE)-- Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has...
Anaconda Biomed Appoints Trent Reutiman New CEO
Jan 7, 2025 · BARCELONA, Spain & MARIN, Calif.-- (BUSINESS WIRE)-- #leadership -- Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has named long-time medtech executive Trent Reutiman as its new CEO.
Anaconda Biomed appoints Trent Reutiman as new CEO
Jan 9, 2025 · Anaconda Biomed has announced that it has named long-time medtech executive Trent Reutiman as its new chief executive officer (CEO).
Trent Reutiman appointed as new CEO - Anaconda Biomed
Jan 10, 2025 · Anaconda Biomed is honored to announce the appointment of Trent Reutiman, a veteran medical technology industry executive, as its new CEO. Based in California’s San Francisco Bay Area, Reutiman will establish a new footprint for the company in the U.S. as it works towards regulatory approval of its ANA5 Advanced Neurovascular Access™ (ANA ...
Trent Reutiman Named New CEO of Anaconda Biomed
Anaconda Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has named medtech execu